Related Experiment Video
Updated: Feb 24, 2026

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Organic Nanoparticle-Based Combinatory Approaches for Gene Therapy
Brahma N Singh1, Prateeksha1, Vijai K Gupta2
1Herbal Nanobiotechnology Lab, Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow-226001, India.
Abstract:
Engineered organic nanoparticle (ONP)-mediated co-delivery of genes and therapeutic agents is emerging as a powerful tool in the treatment of several genetic and non-genetic disorders. The ONP-based combinatory approach provides a technological platform that delivers genes with chemo/radio/photo/immunotherapies for the prevention or treatment of disease progression.
Insights
Engineered organic nanoparticles (ONPs) offer a novel approach for co-delivering genes and therapies. This technology holds promise for treating genetic and non-genetic disorders by combining gene therapy with other treatments.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Therapy
Background:
- Organic nanoparticles (ONPs) are engineered for simultaneous delivery of genetic material and therapeutic agents.
- This combinatory approach targets both genetic and non-genetic diseases.
Discussion:
- ONP-mediated co-delivery integrates gene therapy with conventional treatments like chemotherapy, radiotherapy, phototherapy, and immunotherapy.
- This platform enhances therapeutic efficacy by addressing disease progression through multiple mechanisms.
Key Insights:
- Engineered ONPs facilitate the co-delivery of genes and diverse therapeutic agents.
- The ONP platform enables synergistic treatment strategies for various disorders.
Outlook:
- Further development of ONP-based co-delivery systems is expected to advance precision medicine.
- This approach has the potential to revolutionize the treatment paradigms for complex diseases.
More Related Videos
08:51Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
09:41Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Related Concept Videos
Gene Therapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Microorganisms in Medicine and Therapeutics